Manufacturer record
B. No.: 8S17004: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by B. No.: 8S17004 was declared Not of Standard Quality in January 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 8S17004, Cyproheptadine and Tricholine Oral Drops (CYP-L DROPS) (exp Apr 2020). CDSCO, Sub Zone, Jammu (CDSCO lab) found it not of standard quality: Assay of Cyproheptadine Hydrochloride calculated as Anhydrous Cyproheptadine Hydrochloride. Listed in the January 2019 alert.
Records by type
1 record linked to B. No.: 8S17004 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cyproheptadine and Tricholine Oral Drops (CYP-L DROPS) | Batch 8S17004Mfg May 2018 · Exp Apr 2020 | Assay of Cyproheptadine Hydrochloride calculated as Anhydrous Cyproheptadine HydrochlorideAssay | CDSCO, Sub Zone, JammuCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.